Login / Signup

Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers.

Yael Shachor-MeyouhasHalima Dabaja-YounisAvi MagidRonit LeibaMoran Szwarcwort-CohenRonit AlmogMichal MekelAvi WeissmanGila HyamsVardit GepsteinNethanel A HorowitzHagar Cohen SabanJalal TarabeiaMichael HalberthalKhetam Hussein
Published in: Vaccines (2023)
We found that the fourth vaccine dose had a protective effect, but shorter than the third vaccine dose. Cutoff point of 955 AU/mL was recognized for protection from illness. The decision to vaccinate the population with a booster dose should consider other factors, including the spread of disease at the point, chronic comorbidities and age, especially during shortage of vaccine supply.
Keyphrases
  • sars cov
  • coronavirus disease
  • reduced graphene oxide
  • drug induced